CRISPR Therapeutics AG

NAS:CRSPHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$49.88−0.32%At closeAt close · Wed 21 Oct · ≈ AED 183.18 · Market cap $4.82B · Next earnings Wed 4 Nov · Extended $50.10 +0.44%

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	1.2	0.9	0.2	0.4	0.3	0.4	+19.1%
Cash & short-term investments	1.7	2.4	1.8	1.7	1.9	2.0	+3.8%
Receivables	0.0	0.0	0.0	0.2	0.0	0.0	−100.0%
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	—
Total current assets	1.7	2.4	1.9	1.9	1.9	2.0	+2.5%
Property, plant & equipment	0.1	0.3	0.3	0.3	0.3	0.2	−10.8%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0	—
Long-term investments	0.0	0.0	0.1	0.0	0.0	0.0	—
Total assets	1.8	2.8	2.2	2.2	2.2	2.3	+1.0%
Payables	0.0	0.0	0.0	0.0	0.0	0.0	−24.3%
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	+7.5%
Total current liabilities	0.1	0.1	0.1	0.1	0.1	0.1	+69.9%
Long-term debt	0.0	0.0	0.0	0.0	0.0	0.2	—
Total debt	0.1	0.2	0.2	0.2	0.2	0.4	+76.5%
Net debt	(1.1)	(0.7)	0.0	(0.2)	(0.1)	0.0	+153.3%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	+310.2%
Total liabilities	0.2	0.4	0.4	0.3	0.3	0.3	+10.8%
Total equity	1.7	2.4	1.9	1.9	1.9	1.9	−0.5%
Retained earnings	(0.6)	(0.2)	(0.8)	(1.0)	(1.4)	(1.9)	−42.6%

USD billionsUpdated Mon 3 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.